ELISA Kit for Indoleamine-2,3-Dioxygenase (IDO)

Zhang Y, Shi H, Yang G, et al. Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia. Transl Psychiatry. 2021,11(1):595. doi: 10.1038/s41398-021-01688-x

Kartika R, Wibowo H, Purnamasari D, et al. Altered Indoleamine 2,3-Dioxygenase Production and Its Association to Inflammatory Cytokines in Peripheral Blood Mononuclear Cells Culture of Type 2 Diabetes Mellitus. Int J Tryptophan Res. 2020,13:1178646920978236. doi: 10.1177/1178646920978236

Cheung MB, Sampayo-Escobar V, Green R, et al. Respiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-Dioxygenase. PLoS One. 2016,11(10):e0163709. doi: 10.1371/journal.pone.0163709

Barathan M, Gopal K, Mohamed R, et al. Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes. Apoptosis. 2015,20(4):466-80. doi: 10.1007/s10495-014-1084-y

Pezato R, Pérez-Novo CA, Holtappels G, et al. The expression of dendritic cell subsets in severe chronic rhinosinusitis with nasal polyps is altered. Immunobiology. 2014,219(9):729-36. doi: 10.1016/j.imbio.2014.05.004

Han Y, Chen Z, Yang Y, et al. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma. Hepatology. 2014,59(2):567-79. doi: 10.1002/hep.26694

Azzaoui I, Yahia SA, Chang Y, et al. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects. Blood. 2011,118(13):3549-58. doi: 10.1182/blood-2011-02-338780